Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Roche reaffirms focus on innovation

Roche reaffirms focus on innovation

9th March 2017

Roche has reiterated its intention to continue delivering innovative medicines and diagnostics to patients across the world.

According to Ulrike Engels-Lange, spokeswoman for the company, Roche has recently launched four new medicines and received 14 FDA Breakthrough designations, more than any other pharmaceutical company.

Speaking to BioPharma-Reporter, she insisted the company remains focused on rolling out pioneering options to the healthcare market.

"Our core mission will not change as we are continuously finding new healthcare treatments and solutions that improve and transform patients' lives," Ms Engels-Lange said.

She was speaking after a Twitter poll by BioPharma-Reporter found that people believe Roche is in a stronger position than the likes of Amgen, AbbVie and Janssen to defend against biosimilar competition.

Nearly four in ten respondents voted for Roche, the highest proportion overall in the survey.

With over 20 years of experience within the medical devices market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current medical device roles we have available, you can search for the latest job roles, register your details, or contact the team today.ADNFCR-8000103-ID-801833378-ADNFCR

We have hundreds of jobs available across the Healthcare industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.